Annual Drug Patent Expirations for TYVASO
Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TYVASO.
This drug has twenty-seven patent family members in seven countries.
The generic ingredient in TYVASO is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
